APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Blood Substitute

Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people's demand for blood and make up for the current blood shortage.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people's demand for blood and make up for the current blood shortage.

Selected research

Industry Growth & Trends

Global Artificial Blood Substitute Industry Growth and Trends Forecast to 2032

27 December 202585 pages

Choose your research edition.

Industry ResearchArtificial Blood Substitute Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Blood Substitute Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Artificial Blood Substitute Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Blood Substitute Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Blood Substitute Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people's demand for blood and make up for the current blood shortage.

According to APO Research, the global Artificial Blood Substitute market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Artificial Blood Substitute market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Artificial Blood Substitute market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Artificial Blood Substitute market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Artificial Blood Substitute.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Artificial Blood Substitute market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Artificial Blood Substitute Market by Company

Aurum Biosciences Ltd.

HEMARINA SA

HbO2 Therapeutics

KaloCyte Inc.

SpheriTech Ltd.

NuvOx Pharma

Artificial Blood Substitute Segment by Type

Perfluorocarbon-based Oxygen Carrier (PFBOC)

Hemoglobin-based Oxygen Carrier (HBOC)

Artificial Blood Substitute Segment by Application

Military

Civil

Artificial Blood Substitute Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Blood Substitute market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Blood Substitute and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Blood Substitute.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Artificial Blood Substitute companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Artificial Blood Substitute Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Artificial Blood Substitute Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Artificial Blood Substitute Market Share by Region (2021-2026) Table 4. Global Artificial Blood Substitute Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Artificial Blood Substitute Market Share by Region (2027-2032) Table 6. Global Artificial Blood Substitute Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Artificial Blood Substitute Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Artificial Blood Substitute Market Size Share by Type (2021-2026) Table 9. Global Artificial Blood Substitute Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Artificial Blood Substitute Market Size Share Forecasted by Type (2027-2032) Table 11. North America Artificial Blood Substitute Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Artificial Blood Substitute Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Artificial Blood Substitute Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Artificial Blood Substitute Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Artificial Blood Substitute Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Artificial Blood Substitute Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Artificial Blood Substitute Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Artificial Blood Substitute Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Artificial Blood Substitute Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Artificial Blood Substitute Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Artificial Blood Substitute Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Artificial Blood Substitute Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Artificial Blood Substitute Market Size Share by Application (2021-2026) Table 24. Global Artificial Blood Substitute Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Artificial Blood Substitute Market Size Share Forecasted by Application (2027-2032) Table 26. North America Artificial Blood Substitute Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Artificial Blood Substitute Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Artificial Blood Substitute Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Artificial Blood Substitute Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Artificial Blood Substitute Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Artificial Blood Substitute Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Artificial Blood Substitute Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Artificial Blood Substitute Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Artificial Blood Substitute Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Artificial Blood Substitute Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Artificial Blood Substitute Industry Trends Table 37. Artificial Blood Substitute Industry Drivers Table 38. Artificial Blood Substitute Industry Opportunities and Challenges Table 39. Artificial Blood Substitute Industry Restraints Table 40. Global Artificial Blood Substitute Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Artificial Blood Substitute Revenue Market Share by Company (2021-2026) Table 42. Global Artificial Blood Substitute Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Artificial Blood Substitute Key Company Headquarters & Area Served Table 44. Global Artificial Blood Substitute Company, Product Type & Application Table 45. Global Artificial Blood Substitute Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Artificial Blood Substitute by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Aurum Biosciences Ltd. Company Information Table 49. Aurum Biosciences Ltd. Business Overview Table 50. Aurum Biosciences Ltd. Artificial Blood Substitute Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Aurum Biosciences Ltd. Artificial Blood Substitute Product Portfolio Table 52. Aurum Biosciences Ltd. Recent Development Table 53. HEMARINA SA Company Information Table 54. HEMARINA SA Business Overview Table 55. HEMARINA SA Artificial Blood Substitute Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. HEMARINA SA Artificial Blood Substitute Product Portfolio Table 57. HEMARINA SA Recent Development Table 58. HbO2 Therapeutics Company Information Table 59. HbO2 Therapeutics Business Overview Table 60. HbO2 Therapeutics Artificial Blood Substitute Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. HbO2 Therapeutics Artificial Blood Substitute Product Portfolio Table 62. HbO2 Therapeutics Recent Development Table 63. KaloCyte Inc. Company Information Table 64. KaloCyte Inc. Business Overview Table 65. KaloCyte Inc. Artificial Blood Substitute Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. KaloCyte Inc. Artificial Blood Substitute Product Portfolio Table 67. KaloCyte Inc. Recent Development Table 68. SpheriTech Ltd. Company Information Table 69. SpheriTech Ltd. Business Overview Table 70. SpheriTech Ltd. Artificial Blood Substitute Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. SpheriTech Ltd. Artificial Blood Substitute Product Portfolio Table 72. SpheriTech Ltd. Recent Development Table 73. NuvOx Pharma Company Information Table 74. NuvOx Pharma Business Overview Table 75. NuvOx Pharma Artificial Blood Substitute Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. NuvOx Pharma Artificial Blood Substitute Product Portfolio Table 77. NuvOx Pharma Recent Development Table 78. North America Artificial Blood Substitute Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 79. North America Artificial Blood Substitute Market Size by Country (2021-2026) & (US$ Million) Table 80. North America Artificial Blood Substitute Market Share by Country (2021-2026) Table 81. North America Artificial Blood Substitute Market Size Forecast by Country (2027-2032) & (US$ Million) Table 82. North America Artificial Blood Substitute Market Share Forecast by Country (2027-2032) Table 83. Europe Artificial Blood Substitute Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 84. Europe Artificial Blood Substitute Market Size by Country (2021-2026) & (US$ Million) Table 85. Europe Artificial Blood Substitute Market Share by Country (2021-2026) Table 86. Europe Artificial Blood Substitute Market Size Forecast by Country (2027-2032) & (US$ Million) Table 87. Europe Artificial Blood Substitute Market Share Forecast by Country (2027-2032) Table 88. Asia-Pacific Artificial Blood Substitute Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. Asia-Pacific Artificial Blood Substitute Market Size by Country (2021-2026) & (US$ Million) Table 90. Asia-Pacific Artificial Blood Substitute Market Share by Country (2021-2026) Table 91. Asia-Pacific Artificial Blood Substitute Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. Asia-Pacific Artificial Blood Substitute Market Share Forecast by Country (2027-2032) Table 93. Latin America Artificial Blood Substitute Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Latin America Artificial Blood Substitute Market Size by Country (2021-2026) & (US$ Million) Table 95. Latin America Artificial Blood Substitute Market Share by Country (2021-2026) Table 96. Latin America Artificial Blood Substitute Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Latin America Artificial Blood Substitute Market Share Forecast by Country (2027-2032) Table 98. Middle East & Africa Artificial Blood Substitute Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Middle East & Africa Artificial Blood Substitute Market Size by Country (2021-2026) & (US$ Million) Table 100. Middle East & Africa Artificial Blood Substitute Market Share by Country (2021-2026) Table 101. Middle East & Africa Artificial Blood Substitute Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Middle East & Africa Artificial Blood Substitute Market Share Forecast by Country (2027-2032) Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Artificial Blood Substitute Product Image Figure 3. Global Artificial Blood Substitute Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 5. Global Artificial Blood Substitute Market Share by Region: 2025 VS 2032 Figure 6. Global Artificial Blood Substitute Market Share by Region (2021-2032) Figure 7. North America Artificial Blood Substitute Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Artificial Blood Substitute Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Artificial Blood Substitute Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Artificial Blood Substitute Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Artificial Blood Substitute Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Perfluorocarbon-based Oxygen Carrier (PFBOC) Image Figure 13. Global Perfluorocarbon-based Oxygen Carrier (PFBOC) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Hemoglobin-based Oxygen Carrier (HBOC) Image Figure 15. Global Hemoglobin-based Oxygen Carrier (HBOC) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Artificial Blood Substitute Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Artificial Blood Substitute Market Share by Type 2025 VS 2032 Figure 18. North America Artificial Blood Substitute Market Size Share by Type (2021-2032) Figure 19. Europe Artificial Blood Substitute Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Artificial Blood Substitute Market Size Share by Type (2021-2032) Figure 21. Latin America Artificial Blood Substitute Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Artificial Blood Substitute Market Size Share by Type (2021-2032) Figure 23. Military Image Figure 24. Global Military Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Civil Image Figure 26. Global Civil Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global Artificial Blood Substitute Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Artificial Blood Substitute Market Share by Application 2025 VS 2032 Figure 29. North America Artificial Blood Substitute Market Size Share by Application (2021-2032) Figure 30. Europe Artificial Blood Substitute Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific Artificial Blood Substitute Market Size Share by Application (2021-2032) Figure 32. Latin America Artificial Blood Substitute Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa Artificial Blood Substitute Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 Artificial Blood Substitute Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America Artificial Blood Substitute Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America Artificial Blood Substitute Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America Artificial Blood Substitute Market Share by Country (2021-2032) Figure 39. Europe Artificial Blood Substitute Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe Artificial Blood Substitute Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe Artificial Blood Substitute Market Share by Country (2021-2032) Figure 42. Asia-Pacific Artificial Blood Substitute Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific Artificial Blood Substitute Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific Artificial Blood Substitute Market Share by Country (2021-2032) Figure 45. Latin America Artificial Blood Substitute Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America Artificial Blood Substitute Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America Artificial Blood Substitute Market Share by Country (2021-2032) Figure 48. Middle East & Africa Artificial Blood Substitute Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa Artificial Blood Substitute Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa Artificial Blood Substitute Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • Perfluorocarbon-based Oxygen Carrier (PFBOC)
  • Hemoglobin-based Oxygen Carrier (HBOC)
Applications
  • Military
  • Civil
Companies covered
  • Aurum Biosciences Ltd.
  • HEMARINA SA
  • HbO2 Therapeutics
  • KaloCyte Inc.
  • SpheriTech Ltd.
  • NuvOx Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Artificial Blood Substitute Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Artificial Blood Substitute Market Size by Region (2021-2032)
  5. 1.4.1 Global Artificial Blood Substitute Market Size by Region (2021-2026)
  6. 1.4.2 Global Artificial Blood Substitute Market Size by Region (2027-2032)
  7. 1.5 Key Regions Artificial Blood Substitute Market Size (2021-2032)
  8. 1.5.1 North America Artificial Blood Substitute Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Artificial Blood Substitute Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Artificial Blood Substitute Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Artificial Blood Substitute Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Artificial Blood Substitute Market Size Growth Rate (2021-2032)
2 Artificial Blood Substitute Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Perfluorocarbon-based Oxygen Carrier (PFBOC)
  3. 2.1.2 Hemoglobin-based Oxygen Carrier (HBOC)
  4. 2.2 Global Artificial Blood Substitute Market Size by Type
  5. 2.2.1 Global Artificial Blood Substitute Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Artificial Blood Substitute Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Artificial Blood Substitute Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Artificial Blood Substitute Market Size by Regions
  9. 2.3.1 North America Artificial Blood Substitute Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Artificial Blood Substitute Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Artificial Blood Substitute Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Artificial Blood Substitute Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Artificial Blood Substitute Market Size Breakdown by Type (2021-2026)
3 Artificial Blood Substitute Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Military
  3. 3.1.2 Civil
  4. 3.2 Global Artificial Blood Substitute Market Size by Application
  5. 3.2.1 Global Artificial Blood Substitute Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Artificial Blood Substitute Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Artificial Blood Substitute Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Artificial Blood Substitute Market Size by Regions
  9. 3.3.1 North America Artificial Blood Substitute Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Artificial Blood Substitute Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Artificial Blood Substitute Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Artificial Blood Substitute Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Artificial Blood Substitute Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Artificial Blood Substitute Industry Trends
  2. 4.2 Artificial Blood Substitute Industry Drivers
  3. 4.3 Artificial Blood Substitute Industry Opportunities and Challenges
  4. 4.4 Artificial Blood Substitute Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Artificial Blood Substitute Revenue (2021-2026)
  2. 5.2 Global Artificial Blood Substitute Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Artificial Blood Substitute Key Company Headquarters & Area Served
  4. 5.4 Global Artificial Blood Substitute Company, Product Type & Application
  5. 5.5 Global Artificial Blood Substitute Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Artificial Blood Substitute Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Artificial Blood Substitute Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Artificial Blood Substitute Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Aurum Biosciences Ltd.
  2. 6.1.1 Aurum Biosciences Ltd. Company Information
  3. 6.1.2 Aurum Biosciences Ltd. Business Overview
  4. 6.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Product Portfolio
  6. 6.1.5 Aurum Biosciences Ltd. Recent Developments
  7. 6.2 HEMARINA SA
  8. 6.2.1 HEMARINA SA Company Information
  9. 6.2.2 HEMARINA SA Business Overview
  10. 6.2.3 HEMARINA SA Artificial Blood Substitute Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 HEMARINA SA Artificial Blood Substitute Product Portfolio
  12. 6.2.5 HEMARINA SA Recent Developments
  13. 6.3 HbO2 Therapeutics
  14. 6.3.1 HbO2 Therapeutics Company Information
  15. 6.3.2 HbO2 Therapeutics Business Overview
  16. 6.3.3 HbO2 Therapeutics Artificial Blood Substitute Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 HbO2 Therapeutics Artificial Blood Substitute Product Portfolio
  18. 6.3.5 HbO2 Therapeutics Recent Developments
  19. 6.4 KaloCyte Inc.
  20. 6.4.1 KaloCyte Inc. Company Information
  21. 6.4.2 KaloCyte Inc. Business Overview
  22. 6.4.3 KaloCyte Inc. Artificial Blood Substitute Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 KaloCyte Inc. Artificial Blood Substitute Product Portfolio
  24. 6.4.5 KaloCyte Inc. Recent Developments
  25. 6.5 SpheriTech Ltd.
  26. 6.5.1 SpheriTech Ltd. Company Information
  27. 6.5.2 SpheriTech Ltd. Business Overview
  28. 6.5.3 SpheriTech Ltd. Artificial Blood Substitute Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 SpheriTech Ltd. Artificial Blood Substitute Product Portfolio
  30. 6.5.5 SpheriTech Ltd. Recent Developments
  31. 6.6 NuvOx Pharma
  32. 6.6.1 NuvOx Pharma Company Information
  33. 6.6.2 NuvOx Pharma Business Overview
  34. 6.6.3 NuvOx Pharma Artificial Blood Substitute Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 NuvOx Pharma Artificial Blood Substitute Product Portfolio
  36. 6.6.5 NuvOx Pharma Recent Developments
7 North America
  1. 7.1 North America Artificial Blood Substitute Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Artificial Blood Substitute Market Size by Country (2021-2026)
  3. 7.3 North America Artificial Blood Substitute Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Artificial Blood Substitute Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Artificial Blood Substitute Market Size by Country (2021-2026)
  3. 8.3 Europe Artificial Blood Substitute Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Artificial Blood Substitute Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Artificial Blood Substitute Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Artificial Blood Substitute Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Artificial Blood Substitute Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Artificial Blood Substitute Market Size by Country (2021-2026)
  3. 10.3 South America Artificial Blood Substitute Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Artificial Blood Substitute Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Artificial Blood Substitute Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Artificial Blood Substitute Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst